Targeting TMED4 enhances CD8 + T cell function and CAR T cell efficacy in solid tumors through the IRE1α-autophagy axis
Science Advances · 12.06.2026 · 12 (24)
DOI: 10.1126/sciadv.aee0517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 12.06.2026. Verfasst von Huizi Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Tongren Hospital & Shanghai Institute of Immunology, Center for Immune-Related Diseases Research at Ruijin Hospital, S…. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, CD8-Positive T-Lymphocytes, Endoribonucleases, Autophagy. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Endoplasmic reticulum stress (ERS) and autophagy regulate tumor-infiltrating T cell function and exhaustion, but the underlying mechanisms remain unclear. Here, we identified the ERS-related transmembrane protein TMED4 (transmembrane emp24 domain-containing 4) as a critical regulator of CD8 + T cell antitumor immunity. Tmed4 deletion in T cells enhanced antitumor responses by promoting CD8 + T proliferation, infiltration, and killing capacity, while reducing terminal exhaustion. Mechanistically, Tmed4 deficiency hyperactivated the inositol-requiring enzyme 1α (IRE1α)–X-box binding protein 1 (XBP1) axis and induced autophagy flux in an IRE1α-dependent manner. Genetic deletion of Ern1 (IRE1α) or Becn1 (Beclin1) impaired the antitumor effects of Tmed4 deficiency, underscoring the role of ERS and autophagy in CD8 + T cell function. Moreover, Tmed4 -deficient chimeric antigen receptor T cells (CAR T cells) displayed improved antitumor immunity. Pharmacological inhibition of Tmed4 using antisense oligonucleotide also enhanced CD8 + T cell–mediated tumor control. In summary, our study reveals that TMED4 governs CD8 + T cell effector function and limits terminal exhaustion through IRE1α-driven autophagy, establishing TMED4 as a promising immunotherapeutic target for improving CAR T cell efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Tongren Hospital & Shanghai Institute of Immunology, Center for Immune-Related Diseases Research at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- State Key Laboratory of Chemical Oncogenomics, Shenzhen Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong, China.
- Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Immunology, Zunyi Medical University and Key Laboratory of Cancer Prevention and Treatment of Guizhou Province, Zunyi City, Guizhou Province 563000, China.
- Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
ORCID-Profile: Huizi Wang, Licai Shi, Ke Jiang, Shuyao Wu, Yuexiao Tao, Xin Li, Jun Ni, Emily Jiatong Wu, Sophia Jiaxin Wu, Ming Qin, Lin Xu, Youqiong Ye, Christopher Heeschen, Yu J Cao, Xuefeng Wu
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Ministry of Science and Technology, Taiwan
- National key R&D program of China
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
- FPRC 5 per mille Ministero della Salute
- Italian Ministry of Health
- Fondazione AIRC per la Ricerca sul Cancro
Zitieren
APA
Wang, H., Shi, L., Jiang, K., Wu, S., Jiang, Z., Tao, Y., Li, J., Li, X., Liu, J., Ni, J., Wu, E. J., Wu, S. J., Chen, G., Qin, M., Xu, L., Lai, C. H., Aicher, A., Ye, Y., Heeschen, C., …, & Wu, X. (2026). Targeting TMED4 enhances CD8 + T cell function and CAR T cell efficacy in solid tumors through the IRE1α-autophagy axis. Science Advances, 12(24). https://doi.org/10.1126/sciadv.aee0517
Vancouver
Wang H, Shi L, Jiang K, Wu S, Jiang Z, Tao Y, et al. Targeting TMED4 enhances CD8 + T cell function and CAR T cell efficacy in solid tumors through the IRE1α-autophagy axis. Science Advances. 2026;12(24). doi:10.1126/sciadv.aee0517
BibTeX
@article{Wang2026,
author = {Wang, Huizi and Shi, Licai and Jiang, Ke and Wu, Shuyao and Jiang, Zhenyan and Tao, Yuexiao and Li, Jia and Li, Xin and Liu, Jiamin and Ni, Jun and Wu, Emily Jiatong and Wu, Sophia Jiaxin and Chen, Guang and Qin, Ming and Xu, Lin and Lai, Chu-Hu and Aicher, Alexandra and Ye, Youqiong and Heeschen, Christopher and Cao, Yu J and Wu, Xuefeng},
title = {Targeting TMED4 enhances CD8 + T cell function and CAR T cell efficacy in solid tumors through the IRE1α-autophagy axis},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {24},
doi = {10.1126/sciadv.aee0517}
}
EUVIMED